Okami Medical Announces FDA 510(k) Clearance of the LOBO-7 and LOBO-9 Vascular Occluders To Address A Wide Range Of Peripheral Embolization Cases
June 7, 2022

Okami Medical Announces Fda 510(K) Clearance Of The Lobo-5 Vascular Occluder
December 16, 2020

Okami Medical Announces Closing Of $7.2M Series D Financing
June 24, 2020

Inceptus Announces IPO Of First Portfolio Company
June 2, 2020

Okami Medical Announces First Patients Treated With The LOBO Vascular Occluders
March 5, 2020

Inari Medical Announces Publication of FLARE IDE Study Results
May 7, 2019

Inari Medical Announces First Patient Enrolled in CLOUT Registry Using the ClotTriever Thrombectomy System
September 27, 2018

FlowTriever System from Inari Medical Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism
May 21, 2018

Prospective Clinical Data on the FlowTriever System Confirms Excellent Results in the Treatment of Pulmonary Embolism
April 27, 2018

Inari Medical Announces Completion of $27 Million Series C Financing
March 29, 2018

Inceptus Announces Completion of Series B Financing for Okami Medical
July 25, 2017

Aliso Viejo-based aneurysm treatment maker Sequent acquired for $280 million
June 14, 2016

Inari Medical And Inceptus Medical Announce Receipt Of TCT Innovation Award
November 23, 2015

Inceptus Announces Completion Of Series A Financing For Inari Medical
October 16, 2013

Sequent Medical Awarded U.S. Patent For Microbraid Technology
September 18, 2012

Sequent Medical and Inceptus Medical Announce a Licensing Agreement on Microbraid Technology
March 28, 2012